A pre-treatment quality assurance survey on 384 patients treated with helical intensity-modulated radiotherapy

Sara Bresciani; Anna Miranti; Amalia Di Dia; Angelo Maggio; Christian Bracco; Matteo Poli; Davide Di Spirito; Pietro Gabriele; Michele Stasi

doi:10.1016/j.radonc.2015.12.021

A pre-treatment quality assurance survey on 384 patients treated with helical intensity-modulated radiotherapy

Radiother Oncol. 2016 Mar;118(3):574-6. doi: 10.1016/j.radonc.2015.12.021. Epub 2016 Jan 5.

Authors

Sara Bresciani¹, Anna Miranti², Amalia Di Dia², Angelo Maggio², Christian Bracco², Matteo Poli², Davide Di Spirito², Pietro Gabriele³, Michele Stasi²

Affiliations

¹ Medical Physics Department, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy. Electronic address: [email protected].
² Medical Physics Department, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.
³ Radiotherapy Department, Candiolo Cancer Institute - FPO, IRCCS, Turin, Italy.

PMID: 26778646
DOI: 10.1016/j.radonc.2015.12.021

Abstract

The gamma index pass rate (%GP) of 384 helical Tomotherapy pre-patient quality assurance, acquired with ArcCHECK, is presented, analyzed, and correlated to plan characteristics. Average %GP was higher than 90% and correlated strongly with gamma method, irradiated length, pitch, maximum dose to diodes, and dose per fraction.

Keywords: Gamma index metric; Quality assurance; Tomotherapy.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Female
Gamma Rays
Humans
Male
Neoplasms / radiotherapy*
Quality Assurance, Health Care / methods
Radiotherapy Planning, Computer-Assisted / methods
Radiotherapy Planning, Computer-Assisted / standards
Radiotherapy, Intensity-Modulated / methods
Radiotherapy, Intensity-Modulated / standards*
Surveys and Questionnaires